Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug design.
about
Predicting the points of interaction of small molecules in the NF-κB pathwaySystematic computational analysis of structure-activity relationships: concepts, challenges and recent advances.Modeling approaches for ligand-based 3D similarity.Computational medicinal chemistry in fragment-based drug discovery: what, how and when.Rationalizing tight ligand binding through cooperative interaction networks.Strong nonadditivity as a key structure-activity relationship feature: distinguishing structural changes from assay artifacts.Current and emerging opportunities for molecular simulations in structure-based drug design.Molecular dynamics simulation and linear interaction energy study of D-Glu-based inhibitors of the MurD ligase.Composite multi-parameter ranking of real and virtual compounds for design of MC4R agonists: renaissance of the Free-Wilson methodology.Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925.Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets
P2860
Q33826816-3A20409E-25D5-4B15-824D-87C874BCFC59Q37855888-E3A6C7C8-EDDE-4B6A-AA5F-7131D3631FECQ37855896-507DD716-6F7C-414C-B1BD-DDD0E53CABD9Q37856296-8943A3A2-75A6-41E4-B249-C0B8BAB4671CQ39999558-7124D725-7514-46A1-9989-58D7DC6AD801Q41245616-07D69080-912C-49CD-BE0D-8E98A3C0B89EQ43056042-9939955B-25E4-4CD7-9148-BC90A6F64140Q43703243-BC05ABCB-280F-4EB6-9C71-A2628417A562Q43853536-40586193-FBE4-4E61-9C25-A53BA1B4466DQ52646855-20684825-5041-44C7-9A91-12FCA9627848Q54152447-FA207D3F-AFE5-4A8B-9BF2-6FF6BA246DD6
P2860
Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug design.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Assessment of additive/nonaddi ...... ons for iterative drug design.
@ast
Assessment of additive/nonaddi ...... ons for iterative drug design.
@en
type
label
Assessment of additive/nonaddi ...... ons for iterative drug design.
@ast
Assessment of additive/nonaddi ...... ons for iterative drug design.
@en
prefLabel
Assessment of additive/nonaddi ...... ons for iterative drug design.
@ast
Assessment of additive/nonaddi ...... ons for iterative drug design.
@en
P2093
P50
P356
P1476
Assessment of additive/nonaddi ...... ons for iterative drug design.
@en
P2093
Joaquin Pastor
Trevor Howe
Yogendra Patel
P304
P356
10.1021/JM801070Q
P407
P577
2008-12-01T00:00:00Z